Compounds > oleanolic acid
Page last updated: 2024-08-21

oleanolic acid and Granulocytic Leukemia, Chronic

oleanolic acid has been researched along with Granulocytic Leukemia, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cipak, L; Grausova, L; Miadokova, E; Novotny, L; Rauko, P1
Gattass, CR; Maia, RC; Rumjanek, VM; Vasconcelos, FC1
Andreeff, M; Beran, M; Dunner, K; Kantarjian, H; Kondo, S; Konopleva, M; Korchin, B; Kurinna, S; Ruvolo, P; Samudio, I1

Other Studies

3 other study(ies) available for oleanolic acid and Granulocytic Leukemia, Chronic

ArticleYear
Dual activity of triterpenoids: apoptotic versus antidifferentiation effects.
    Archives of toxicology, 2006, Volume: 80, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Doxorubicin; Drug Combinations; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Oleanolic Acid; Triterpenes; Ursolic Acid

2006
Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile.
    Investigational new drugs, 2007, Volume: 25, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Blast Crisis; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Oleanolic Acid

2007
Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Dose-Response Relationship, Drug; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; Oleanolic Acid; Oxidation-Reduction; Oxygen; Piperazines; Pyrimidines; Reactive Oxygen Species

2008